Details

---

Manufacturer
Sun Pharmaceutical Industries Ltd.(INDIA)

Registraction Number
MAL24076018AZ

Contents:
Each capsule contains 150 mg of nintedanib (free base), which corresponds to 180.6 mg of nintedanib esilate. The capsule shell includes ingredients like gelatine, glycerol, titanium dioxide, iron oxide red and yellow, and black ink.
Indication:
NINTESUN 150 is primarily used for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other chronic fibrosing interstitial lung diseases (ILDs) where lung fibrosis continues to worsen. It is also indicated for systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Instructions:

• Dosage: The recommended dose is 150 mg twice daily, approximately 12 hours apart.
• Administration: Take the capsules orally with water. Do not chew or crush the capsules.
• Precautions: Ensure you are not pregnant before starting the medication. Women of childbearing age should use effective contraception.
• Monitoring: Regular monitoring by a healthcare professional is necessary to manage any adverse reactions.